NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/05/2024
Back to search
Official data from USPTO
GENFIT TOWARDS BETTER MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/23/2025
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
04/06/2017
Registration date
02/13/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2024
Last transaction
05/23/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Loos, FR
Examiner
MURRAY, GEORGE
Law office
N30
Current location
TMO LAW OFFICE 121
Mark description
The mark consists of the word "GENFIT" over the words "Towards Better Medicine" all appearing in white, with a partial white sphere containing a fanciful design appearing in white and blue, and all the elements centered within a blue rectangle.
Holders and representatives
Holders
GENFIT
Representatives
Ronald M. Kachmarik Cooper Legal Group LLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disordersfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; cultures of microorganism for medicalpharmaceutical or veterinary use; cells preparations for medicalpharmaceutical or veterinary usein particular for gene therapy or cell therapy; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary use; sanitary preparations for medical use; dietetic foodstuffs for medical use; food supplements
Class 42
Pharmaceutical researchresearch for the discovery of new drugs; scientific researchin particular in the medicalbiomedicalchemicalgeneticpharmaceutical and veterinary fields; basic and applied scientific research; technical research in the field of pharmaceutical studies; screening and selection of molecules for scientific research purposes; development and validation of biological testsof cell tests and of genetic tests; Functional analysis of genomics to identifycharacterizevalidate or develop biologically active molecules; analysis of biological substances in biologic fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering surveying; analysis of technical projects; professional consultancynot connected with the conduct of businessin the field of scientific research; research and development of new pharmaceutical products for third parties; scientific research in the field of pharmacy
Class 44
Professional consultancynot connected with the conduct of businessin the field of hepatologygastroenterologycholestaticcardiovascularmetabolicinflammationautoimmune therapy
Publications
History of USPTO decisions and trademark events.
22 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/04/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/06/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/13/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/13/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/28/2017
PUBO
PUBLISHED FOR OPPOSITION
11/28/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/26/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/20/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/16/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2017
ALIE
ASSIGNED TO LIE
10/11/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/25/2017
GNRT
NON-FINAL ACTION E-MAILED
04/25/2017
CNRT
NON-FINAL ACTION WRITTEN
04/25/2017
DOCK
ASSIGNED TO EXAMINER
04/25/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/13/2017
NWAP
NEW APPLICATION ENTERED
04/10/2017
Continuous trademark protection
Get notified about every new filing that threatens GENFIT TOWARDS BETTER MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.